231 related articles for article (PubMed ID: 27893332)
1. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.
Fischer S; Tandstad T; Wheater M; Porfiri E; Fléchon A; Aparicio J; Klingbiel D; Skrbinc B; Basso U; Shamash J; Lorch A; Dieckmann KP; Cohn-Cedermark G; Ståhl O; Chau C; Arriola E; Marti K; Hutton P; Laguerre B; Maroto P; Beyer J; Gillessen S
J Clin Oncol; 2017 Jan; 35(2):194-200. PubMed ID: 27893332
[TBL] [Abstract][Full Text] [Related]
2. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
3. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
5. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
[TBL] [Abstract][Full Text] [Related]
6. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma.
Aparicio J; García del Muro X; Maroto P; Paz-Ares L; Alba E; Sáenz A; Terrasa J; Barnadas A; Almenar D; Arranz JA; Sánchez M; Fernández A; Sastre J; Carles J; Dorca J; Gumà J; Yuste AL; Germà JR;
Ann Oncol; 2003 Jun; 14(6):867-72. PubMed ID: 12796024
[TBL] [Abstract][Full Text] [Related]
7. Two cycles of adjuvant carboplatin for clinical stage 1 testicular seminoma in New Zealand centres: A retrospective analysis of efficacy and long-term events.
Chandran EA; Chindewere A; North R; Jameson MB
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1310. PubMed ID: 33103860
[TBL] [Abstract][Full Text] [Related]
8. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
[TBL] [Abstract][Full Text] [Related]
9. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
10. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Terbuch A; Posch F; Bauernhofer T; Jost PJ; Partl R; Stranzl-Lawatsch H; Baciarello G; Fizazi K; Giannatempo P; Verzoni E; Sweeney C; Ravi P; Tran B; Basso U; White J; Vincenzi B; Oing C; Cutuli HJ; Dieckmann KP; Gamulin M; Chovanec M; Fankhauser CD; Heidenreich A; Mohamad O; Thibault C; Fischer S; Gillessen S;
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):825-832. PubMed ID: 35461737
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
Oliver RT; Mead GM; Rustin GJ; Joffe JK; Aass N; Coleman R; Gabe R; Pollock P; Stenning SP
J Clin Oncol; 2011 Mar; 29(8):957-62. PubMed ID: 21282539
[TBL] [Abstract][Full Text] [Related]
13. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
14. Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?
Oliver RT; Edmonds PM; Ong JY; Ostrowski MJ; Jackson AW; Baille-Johnson H; Williams MV; Wiltshire CR; Mott T; Pratt WR
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):3-8. PubMed ID: 8175442
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.
Oliver RT; Mason MD; Mead GM; von der Maase H; Rustin GJ; Joffe JK; de Wit R; Aass N; Graham JD; Coleman R; Kirk SJ; Stenning SP;
Lancet; 2005 Jul 23-29; 366(9482):293-300. PubMed ID: 16039331
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?
Dieckmann KP; Brüggeboes B; Pichlmeier U; Küster J; Müllerleile U; Bartels H
Urology; 2000 Jan; 55(1):102-6. PubMed ID: 10654903
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin in clinical stage I seminoma: too much and too little at the same time.
Bosl GJ; Patil S
J Clin Oncol; 2011 Mar; 29(8):949-52. PubMed ID: 21282532
[No Abstract] [Full Text] [Related]
19. Management of testicular cancer--16 years' experience from southwest Finland.
Sundström J; Salminen E; Nurmi M; Toppari J; Pöllänen P; Pelliniemi LJ; Huhtala S; Rajala P; Laato M
Scand J Urol Nephrol; 2001 Feb; 35(1):21-5. PubMed ID: 11291682
[TBL] [Abstract][Full Text] [Related]
20. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]